Institutional investors purchased a net $2.2 million shares of LIFE during the quarter ended March 2016 and now own 45.86% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JACKSON PARK CAPITAL LLC Bought 66.0 Thousand shares of aTyr Pharma Inc
CREATIVE PLANNING, INC. Bought 8.0 Thousand shares of aTyr Pharma Inc